Product Information
CLONAZEPAM 2 MG TABLET is a generic product labeled by NorthStar Rx LLC, priced at $0.0378 per EA under NDC 72603030901. Its NADAC has been published 65 times since Apr 2, 2025.
Strength
2 mg/1
Manufacturer
NorthStar Rx LLCNDC
72603030901
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
CLONAZEPAMApproval Type
Generic (ANDA)
FDA Application
ANDA075468On Market Since
10/6/2000
Pharmacological Classes
Price Statistics
The NADAC for CLONAZEPAM 2 MG TABLET has been published 65 times since Apr 2, 2025, and over the history we have for it it has declined 12.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0378 per EA |
|---|---|
| All-time high | $0.0436 (Sep 10, 2025) |
| All-time low | $0.0378 (Jun 17, 2026) |
| 52-week high | $0.0436 |
| 52-week low | $0.0378 |
| Median price | $0.0420 |
| Average price | $0.0414 |
| Largest weekly change | -3.3% (Apr 22, 2026) |
| Weeks tracked | 65 |
| Tracking since | Apr 2, 2025 |
Generic Alternatives
The matcher finds 6 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 6 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of CLONAZEPAM 2 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CLONAZEPAM 2 MG TABLET, manufactured by NorthStar Rx LLC, is $0.0378 per EA (NDC 72603030901), effective Jun 24, 2026.
How has the price of CLONAZEPAM 2 MG TABLET changed over time?
Over the history we have for it, the NADAC for CLONAZEPAM 2 MG TABLET has declined 12.6%. It has been tracked across 65 weekly CMS publications since Apr 2, 2025.
What are the highest and lowest recorded NADAC prices for CLONAZEPAM 2 MG TABLET?
Since Apr 2, 2025, the NADAC for CLONAZEPAM 2 MG TABLET has ranged from a low of $0.0378 (Jun 17, 2026) to a high of $0.0436 (Sep 10, 2025), with a median of $0.0420 per EA.
Are there cheaper alternatives to CLONAZEPAM 2 MG TABLET?
6 NADAC-published products share the same active ingredient, strength, and dosage form as CLONAZEPAM 2 MG TABLET, but none are currently priced below it.
Who manufactures CLONAZEPAM 2 MG TABLET?
CLONAZEPAM 2 MG TABLET (NDC 72603030901) is labeled by NorthStar Rx LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification